Combining Intense Pulsed Light (IPL) and Non-Ablative Fractional Treatments
Patients See Improvement in Wrinkles and Pigment/Discoloration
For Immediate Release
October 21, 2013
Wausau, WI – Research conducted by C. Stanley Chan, M.D., Nazanin Saedi, M.D., Clinzo Mickle, MD., and Jeffrey S. Dover, M.D., FRCPC, was selected as Editor’s Choice for the September 2013 issue of Lasers in Surgery and Medicine (LSM).
The manuscript titled “Combined Treatment for Facial Rejuvenation Using an Optimized Pulsed Light Source Followed by a Fractional Non-Ablative Laser” was published in LSM, the official journal of the American Society for Laser Medicine and Surgery, Inc. (ASLMS).
In the study, the authors looked at how the combination of laser treatments can potentially increase the effectiveness of treatment without the additional downtime for patients. They evaluated the safety and effectiveness of combining Intense Pulsed Light (IPL) and non-ablative fractional treatments, both of which are popular procedures.
“Ten patients received the combination treatment and 26 patients only received treatment with a non-ablative fractional laser,” said Dr. Chan.
Currently, Dr. Chan is in practice with The Permanente Medical Group in Elk Grove, CA. His focus has been primarily on Mohs surgery, a specialized form of skin cancer surgery that he hopes to re-incorporate into his practice via facial rejuvenation.
“The combination of IPL with a non-ablative fractional laser during the same treatment session was safe and effective,” explained Dr. Mickle.
Dr. Mickle is currently employed at Integrated Dermatology of K Street in Washington, DC. He has clinical interests in the diagnosis and treatments of all aspects of medical dermatology as well as the education of dermatology residents and medical students.
“Patients were able to see improvement in their wrinkles as well as improvement in their pigment/discoloration,” said Dr. Saedi.
Dr. Saedi is an assistant professor and director of laser surgery and cosmetic dermatology in the department of dermatology and cutaneous biology at Thomas Jefferson University in Philadelphia, PA.
“With this combination treatment, patients will hopefully see more dramatic results after just one treatment session,” explained Dr. Dover.
Dr. Dover is the co-director of SkinCare Physicians in Chestnut Hill, MA, Associate Clinical Professor of dermatology at Yale University School of Medicine, and president of ASLMS. He is also the author of over 350 scientific publications, and has co-authored and edited over 40 textbooks.
The Editor-in-Chief of LSM, J. Stuart Nelson, M.D., Ph.D. commented on the study, “Combination laser treatments provide the opportunity to potentially treat patients more effectively with less overall downtime. There are relatively few studies; however, that have specifically looked at non-ablative fractional lasers in combination with other laser technologies. Only one other study by Kearney and Brew has evaluated the combination of intense pulsed light and non-ablative fractional photothermolysis. The Chan et al. study provides supporting evidence that combining these two laser modalities in a single session can be performed safely and provide impressive results. Further reports describing combination treatments will help further evolve the field and improve patient outcomes.”
Editor’s Choice is an exclusive article published in LSM, the official journal of ASLMS.
To view the complete manuscript, visit: http://www.aslms.org/professional/lsmeditorschoice.shtml.
- 30 -
hr/IPL_2013
tel 715-301-1634
mobile 715-498-1242
fax 715-848-2493
email matt@aslms.org
web www.aslms.org
The American Society for Laser Medicine and Surgery, Inc. (ASLMS) is the world's largest scientific organization dedicated to promoting research, education and high standards of clinical care in the field of medical laser applications. It provides a forum for the exchange of scientific information and participates in communicating the latest developments in laser medicine and surgery to clinicians, research investigators, government and regulatory agencies, and the public.
Tags: